Veeva Systems (NYSE:VEEV) Updates Q3 2027 Earnings Guidance

Veeva Systems (NYSE:VEEV) updated its third quarter 2027 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 2.330-2.340 for the period, compared to the consensus estimate of 2.160. The company issued revenue guidance of $932.0 million-$935.0 million, compared to the consensus revenue estimate of $917.9 million. Veeva Systems also updated its FY 2027 guidance to 9.210-9.210 EPS.

Veeva Systems Stock Performance

NYSE:VEEV opened at $244.72 on Thursday. The company has a market capitalization of $39.75 billion, a price-to-earnings ratio of 43.62, a price-to-earnings-growth ratio of 1.06 and a beta of 0.92. Veeva Systems has a one year low of $148.05 and a one year high of $310.50. The stock has a 50-day simple moving average of $203.41 and a 200 day simple moving average of $183.04.

Veeva Systems (NYSE:VEEV) last announced its quarterly earnings data on Wednesday, August 26th. The technology company reported $2.35 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.22 by $0.13. Veeva Systems had a return on equity of 13.72% and a net margin of 28.37%.The firm had revenue of $927.96 million for the quarter, compared to analysts’ expectations of $905.38 million. During the same quarter in the prior year, the firm posted $1.99 earnings per share. Veeva Systems’s revenue for the quarter was up 17.6% compared to the same quarter last year. Veeva Systems has set its FY 2027 guidance at 9.210-9.210 EPS and its Q3 2027 guidance at 2.330-2.340 EPS. On average, equities research analysts forecast that Veeva Systems will post 6.65 EPS for the current fiscal year.

Analysts Set New Price Targets

VEEV has been the topic of a number of research reports. Royal Bank Of Canada reissued an “outperform” rating and set a $275.00 target price on shares of Veeva Systems in a report on Thursday, June 4th. Wall Street Zen lowered shares of Veeva Systems from a “buy” rating to a “hold” rating in a report on Monday, August 3rd. Oppenheimer boosted their price objective on shares of Veeva Systems from $225.00 to $300.00 and gave the company an “outperform” rating in a research report on Monday, August 17th. Weiss Ratings upgraded shares of Veeva Systems from a “hold (c-)” rating to a “hold (c)” rating in a research note on Wednesday, August 12th. Finally, Evercore reiterated an “outperform” rating and set a $185.00 price objective on shares of Veeva Systems in a research note on Thursday, June 4th. Nineteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Veeva Systems currently has an average rating of “Moderate Buy” and an average price target of $256.62.

Insider Buying and Selling at Veeva Systems

In related news, insider Thomas D. Schwenger sold 36,000 shares of the stock in a transaction dated Thursday, August 13th. The shares were sold at an average price of $250.23, for a total value of $9,008,280.00. Following the sale, the insider owned 19,449 shares of the company’s stock, valued at $4,866,723.27. This trade represents a 64.92% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 10.60% of the stock is currently owned by company insiders.

Veeva Systems News Summary

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Quarterly results exceeded expectations. Veeva reported fiscal Q2 revenue of $928.0 million, up 17.6% year over year, including subscription revenue of $766.8 million, up 16%. Earnings of $2.35 per share surpassed the $2.22 consensus estimate. Veeva Announces Fiscal 2027 Second Quarter Results
• Positive Sentiment: Forward guidance was materially above Wall Street forecasts. Veeva guided fiscal Q3 revenue to $932 million-$935 million and EPS to $2.33-$2.34, compared with consensus estimates of $917.9 million and $2.16, respectively. Fiscal 2027 revenue guidance was approximately $3.7 billion and EPS guidance was $9.21, both above analyst expectations.
• Positive Sentiment: AI and CRM momentum supported the outlook. Management expects the first customers to go live with Falcon, its next-generation AI offering, this year, while targeting retention of more than 70% share of the life sciences CRM market. Management also highlighted AI-driven demand and continued adoption of its Vault platform. Veeva CRM and Falcon Update
• Positive Sentiment: Major customer wins strengthened the competitive case. Regeneron and Biogen committed to Veeva Vault CRM globally, providing evidence that Veeva is maintaining its market leadership and expanding adoption among large biopharmaceutical companies. Veeva Vault CRM Selected by Regeneron
• Neutral Sentiment: Needham reaffirmed a Buy rating, while Piper Sandler initiated coverage. These analyst actions add support but are less significant than the earnings and guidance updates. Needham Reaffirms Buy Rating
• Neutral Sentiment: Veeva’s 28.37% net margin, strong balance-sheet profile, and recurring subscription model remain attractive, although the stock’s elevated valuation—with a reported P/E ratio above 43—leaves less room for execution disappointments.

Hedge Funds Weigh In On Veeva Systems

Institutional investors and hedge funds have recently bought and sold shares of the stock. State Street Corp lifted its stake in shares of Veeva Systems by 2.4% in the 4th quarter. State Street Corp now owns 3,589,425 shares of the technology company’s stock worth $801,267,000 after acquiring an additional 85,695 shares during the period. AQR Capital Management LLC raised its holdings in Veeva Systems by 31.2% during the third quarter. AQR Capital Management LLC now owns 2,412,210 shares of the technology company’s stock worth $706,078,000 after purchasing an additional 574,164 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in Veeva Systems by 12.3% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,728,089 shares of the technology company’s stock worth $385,761,000 after purchasing an additional 189,093 shares during the period. Wellington Management Group LLP boosted its stake in Veeva Systems by 1.3% during the 3rd quarter. Wellington Management Group LLP now owns 1,466,827 shares of the technology company’s stock valued at $436,982,000 after purchasing an additional 18,349 shares in the last quarter. Finally, Bank of America Corp DE increased its position in shares of Veeva Systems by 11.4% during the 3rd quarter. Bank of America Corp DE now owns 1,419,717 shares of the technology company’s stock valued at $422,948,000 after purchasing an additional 144,982 shares during the period. Institutional investors own 88.20% of the company’s stock.

Veeva Systems Company Profile

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.